Showing 4 results for Rezayatmand
Ahmadreza Riaziat, Keyvan Rahmani, Alireza Farshid, Reza Rezayatmand,
Volume 2, Issue 2 (9-2019)
Abstract
Introduction: As the pharmaceuticals play a decisive role in promoting health of the community, its consumption and cost puts the burden on society. Regarding the role of insurance organizations in health system financing and the lack of a description of the costly services of the health insurance organization in Iran, the present study aims to identify the most costly pharmaceutical items of the health insurance organization and provide solutions to reduce the consumption of identified items.
Methods: The present study was a descriptive cross-sectional study conducted in 2017 based on 2015 data. Information was obtained from the medical documentation software of the provincial health insurance offices throughout the country. In order to improve the accuracy of the information and the accuracy of the selection of the most costly services, duplications were identified and corrected. Data analysis was done using Excel 2013 software. The initial questionnaire containing 20 costly services identified at the previous stage was completed by the chief of provincial health insurance offices and relevant responsible experts. The proposed interventions were reviewed and, after removing duplicates, were classified as special interventions for each service and non-specific interventions for all of them.
Results: The cost of 20 items of costly pharmaceuticals has accounted for 35% of total pharmaceuticals costs of health insurance organization in 2015. Among the most important non-specific interventions identified, recording drug prescription (more monitoring of drug use), proper education of rational drug prescription, the presence of a trusted physician to approve drugs, staggered franchising, the pharmaceuticals cost-effectiveness studies and culture empowerment in Prescribing and consumption of medication (increasing general information).
Conclusions: With the knowledge of costly services, in order to balance the costs of the health insurance organization, it is necessary that various policies be put in place by the health insurance organization in order to control costs.
Masud Ferdosi, Mohammad Reza Rezayatmand, Maryam Barati,
Volume 2, Issue 3 (12-2019)
Abstract
Introduction: Proper tariff setting of health services in addition to reduction the health sector resources wastages, increases the healthcare providers’ incentives in delivering effective services. The purpose of this study was to identify the waste points of HTP hospital resources, and to offer some solutions in medical tariffs setting.
Methods: This is an original applied research conducted employing a content analysis method. In order to identify hospital resources wastages and cost control approaches, PubMed, Irandoc, SID, Google Scholar and Magiran databases were searched with keywords wastage- tariff- Health Transformation- Cost and Cost Control Plan. Related articles were extracted. The nominal group technique was used to classify the wastes, and a focus group discussion with 33 participatants of senior managers and experts of hospitals, insurance organizations and academic members of Isfahan University of Medical Sciences was used to confirm the solutions.
Results: The mos t important wastages caused by diagnostic and Therapeutic services tariffs were disparities in the income levels of some specialists, imbalances in the income of various specialist groups, imbalances in physicians’ earnings versus other medical personnel’s, and induced demand. The most important cost containment strategies included tariff review, reconstructing the health sector financial structures, and reinforcing accurate pricing, reducing induced demands, implementing family physician and referral systems, and tracing health services abuse.
Conclusion: The Iran HTP and any other reform plan in the health system will have its own costs, so that if the wasted resources are not identified and controlled, the success of the plan would be in danger.
Keyvan Rahmani, Ahmadreza Riaziat, Alireza Farshid, Reza Rezayatmand,
Volume 3, Issue 2 (8-2020)
Abstract
Introduction: The increasing demand for health services has made the health system constantly faced with inconsistent challenges of improving performance and cost control. The prerequisite for taking appropriate cost control measures is a detailed description of the situation. The aim of this paper is to identify the most expensive outpatient laboratory services covered by the Health Insurance Organization and cost control strategies.
Methods: This study was a cross-sectional descriptive study that was done in 2017 based on data from 2015. Laboratory cost data were obtained from the Medical Records System of the Provincial Health Insurance Offices of the whole country and analyzed using Excel 2013 software. Chiefs of provincial Medical Records Bureau and responsible experts were asked to propose cost-cutting interventions pertaining to identified the costliest services. Suggested interventions were reviewed and after excluding duplicates, they were categorized as specific interventions for each service and non-specific interventions.
Results: The most costly outpatient laboratory services accounted for approximately half of the costs of the Iranian Health Insurance Organization. TSH measurement tests, blood cholesterol, CBC and vitamin D levels are at the top of the costly lab services. The most important cost control interventions include family physician and referral system implementation, monitoring of physicians and Para clinical centers, insurance aggregation, observing costly centers, preparing performance reports to physicians, empowering insureds and creating electronic health records.
Conclusion: It is suggested that appropriate policies regarding the strategies proposed here by insurance organizations and the Ministry of Health and Medical Education need be taken into consideration in order to more effectively control and manage the rising costs of health services.
Marzieh Salimi Bani, Behjat Taheri, Mohammad Ghari, Ali Ahmadi, Mohammadreza Rezayatmand, Mojtaba Baktashian, Saeed Abbasi,
Volume 4, Issue 4 (3-2022)
Abstract
Introduction: Intermediate Care Unit is for patients who do not need intensive care but cannot be admitted to normal wards. The aim of this study was to evaluate the frequency of patients in need of intermediate care in Al-Zahra Hospital, Isfahan, Iran in 2020.
Methods: This research was applied and descriptive. Patients admitted to some normal wards and intensive care units of Al-Zahra Hospital were considered as the study population. To determine the sample size, 240 samples were obtained, which were randomly distributed in 14 checklists in each section. The data collection tool was a researcher-made checklist that the reliability of the checklist was 0.8 using Cronbach's alpha test. The collected data were analyzed by STST software.
Results: Of the 31 patients who died, 5 patients (2.44%) were admitted to the intensive care unit, 12 patients (12.09%) were admitted to the intensive care unit, and 14 patients (19.23%) were admitted to the intensive care unit. Due to the size of the gamma effect (0.96), the formation of the intermediate care unit in Al-Zahra Medical Center has a strong effectiveness (gamma between 0.8 to 1.19 indicates strong effectiveness).
Conclusion: Examining the demographics of patients in need of transfer to the IMCU ward and also the feasibility of its establishment, the findings indicate the existence of hospitalization criteria for a number of patients in the interstitial care ward and confirm the effectiveness of its establishment. The desired infrastructure will be able to improve care and mortality outcomes while reducing hospitalization costs and overall patient care.
